Identifying Drug Targets for Chagas' Disease
Author Information
Author(s): Capriles Priscila VSZ, Guimarães Ana CR, Otto Thomas D, Miranda Antonio B, Dardenne Laurent E, Degrave Wim M
Primary Institution: Grupo de Modelagem Molecular de Sistemas Biológicos, Laboratório Nacional de Computação Científica, LNCC/MCT, Brazil
Hypothesis
Can we find new drug targets for Chagas' disease by comparing proteins from Trypanosoma cruzi and humans?
Conclusion
The study identified 397 enzyme models from T. cruzi that could serve as potential drug targets for Chagas' disease treatment.
Supporting Evidence
- 3,286 protein models were created from T. cruzi proteins.
- 397 enzyme sequences were identified, including 356 homologous, 3 analogous, and 38 specific to T. cruzi.
- Two enzymes, 2,4-dienoyl-CoA reductase and triacylglycerol lipase, were highlighted as potential drug targets.
Takeaway
Scientists looked at proteins from a parasite that causes Chagas' disease and found some that could be good targets for new medicines.
Methodology
The study used comparative modeling techniques to create 3D models of proteins from T. cruzi and compared them to human proteins.
Limitations
The genome of T. cruzi has not been completely assembled, which may affect the accuracy of the protein models.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website